Product Images Flovent Hfa
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 15 images provide visual information about the product associated with Flovent Hfa NDC 50090-0916 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
fluticasone propionate chemical structure - floventhfa spl graphic 01
Figure 1. A 12-Week Clinical Trial in Subjects Aged 12 Years and Older Inadequately Controlled on Bronchodilators Alone: Mean Percent Change from Baseline in FEV1 Prior to AM Dose (Trial 1) - floventhfa spl graphic 02
This appears to be a report of a clinical trial or study involving a medication called "FLOVENT HFA 88 mcg" administered twice daily to individuals (group referred to as "Placebo"). The study appears to have evaluated the change in "FEV" (which likely stands for forced expiratory volume) from a baseline measurement at various time points (all labeled with the letter "T") up to an endpoint labeled "12". The rest of the text does not appear to provide any additional useful information about the study.*
Figure 2. A 12-Week Clinical Trial in Subjects Aged 12 Years and Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change from Baseline in FEV1 Prior to AM Dose (Trial 2) - floventhfa spl graphic 03
This appears to be a chart or graph showing the change from baseline in FEV (forced expiratory volume) for various treatments, including a placebo and different doses of FLOVENT HFA. The chart shows the percentage of change at different endpoints measured over a period of 12 weeks.*
Figure 3. A 16-Week Clinical Trial in Subjects Aged 12 Years and Older Requiring Chronic Oral Prednisone Therapy: Change in Maintenance Prednisone Dose - floventhfa spl graphic 04
The text represents a graph showing the percentage of subjects with an increase or reduction in dose of FLOVENT HFA medication. The graph displays the percentage of subjects on the Y-axis ranging from 0% to 60% and the different dose levels on the X-axis. The percentage of subjects is shown for Placebo, FLOVENT HFA 440mcg twice daily, and FLOVENT HFA 880 mcg twice daily.*
Figure A - floventhfa spl graphic 05
The text describes a metal canister with a dark orange plastic actuator and mouthpiece. It also has a counter peach cap.*
Figure B - floventhfa spl graphic 06
Fgure C - floventhfa spl graphic 07
Figure D - floventhfa spl graphic 08
Figure E - floventhfa spl graphic 09
The text refers to the attributes of a mouthpiece, including its position (down), color (dark orange), and the fact that it is a mouthpiece. The context and purpose of the mouthpiece is not given, so no further information can be determined.*
Figure F - floventhfa spl graphic 10
This is a simple instruction that tells the reader to exhale or breathe out as much air as they can. It is likely a part of a breathing technique or exercise designed to improve lung capacity or relaxation.*
Figure G - floventhfa spl graphic 11
Figure H - floventhfa spl graphic 12
Figure I - floventhfa spl graphic 13
floventhfa spl graphic 14
Label Image - lbl500900916
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.